Profile
Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.
Hans Klingemann active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNITYBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Hans Klingemann
| Companies | Position | End |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Director/Board Member | 10/06/2016 |
Rush University Medical Center
Rush University Medical Center Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Corporate Officer/Principal | - |
Bone Marrow & Cancer Foundation, Inc.
Bone Marrow & Cancer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides financial assistance and free support services to bone marrow/stem cell transplant patients and their families | Director/Board Member | - |
| IMMUNITYBIO, INC. | Founder | - |
Training of Hans Klingemann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush University Medical Center
Rush University Medical Center Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Bone Marrow & Cancer Foundation, Inc.
Bone Marrow & Cancer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides financial assistance and free support services to bone marrow/stem cell transplant patients and their families | Commercial Services |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
University of Würzburg Medical School
University of Würzburg Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunityBio, Inc.
ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
- Stock Market
- Insiders
- Hans Klingemann
















